Newsroom Stories

A new multidisciplinary center focused on biomolecular condensates — distinct molecular communities that make up the building blocks of life — has launched at the McKelvey School of Engineering.

If changes at Twitter conflict with businesses’ values, it’s time for companies to re-evaluate use of the social media platform, said Olin Business School marketing expert Michael Wall.

New measurements from Cygnus X-1, reported Nov. 3 in the journal Science, represent the first observations of a mass-accreting black hole from the Imaging X-Ray Polarimetry Explorer (IXPE) mission, an international collaboration between NASA and the Italian Space Agency. The lead author of the new study is physicist Henric Krawczynski in Arts & Sciences.

Presented by student group Ashoka, Washington University’s annual Diwali performance is a celebration of South Asian dance and song. It also serves as a showcase for the region’s colorful fashions.

Using data from the newly released Uniform Appraisal Dataset, which includes 47.3 million home appraisals conducted over the last decade, WashU’s Elizabeth Korver-Glenn and Junia Howell of the University of Illinois Chicago demonstrate stark inequalities in appraisal values between homes in white neighborhoods and communities of color.

Steve Smith, a leading congressional politics scholar, discusses the factors making 2022 midterms difficult to predict, what’s ahead for the second half of President Joe Biden’s term and the impact the midterm election could have on the GOP’s future.

A study from Washington University School of Medicine shows that as patients age, Huntington’s disease impairs autophagy, which eliminates waste from cells.

Research from the lab of Kimberly Parker, at the McKelvey School of Engineering, shows that amines, sometimes used as an additive in herbicides, can enter the atmosphere, where they pose risks for human and environmental health.

Erik Henriksen, associate professor of physics, and Kater Murch, professor of physics, both in Arts & Sciences, each will receive $1.25 million from the Gordon and Betty Moore Foundation for their projects over the next five years. Both are founding members of the university’s Center for Quantum Leaps.

Researchers at the School of Medicine are working toward a treatment for neurodegenerative diseases, among them peripheral neuropathies and Parkinson’s disease, that targets SARM1, a key molecule in the death of axons, the wiring of the nervous system.